These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18768589)

  • 1. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy.
    Song HK; Lee MH; Kim BK; Park YG; Ko GJ; Kang YS; Han JY; Han SY; Han KH; Kim HK; Cha DR
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1485-94. PubMed ID: 18768589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells.
    Giannico G; Cortes P; Baccora MH; Hassett C; Taube DW; Yee J
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F57-65. PubMed ID: 16896180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells.
    Huang Q; Guo Y; Zeng H; Xie W; Yan H; Ding H
    Endocr Res; 2011; 36(3):93-100. PubMed ID: 21314328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SREBP-1 activation by glucose mediates TGF-β upregulation in mesangial cells.
    Uttarwar L; Gao B; Ingram AJ; Krepinsky JC
    Am J Physiol Renal Physiol; 2012 Feb; 302(3):F329-41. PubMed ID: 22031849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats.
    Sun Q; Li L; Li R; Yang M; Liu H; Nowicki MJ; Zong H; Xu J; Yang G
    Ann Med; 2009; 41(4):311-20. PubMed ID: 19263259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of aldosterone on the expression of plasminogen activator inhibitor-1 in renal mesangial cells: experiment with rat renal mesangial cells].
    Yuan J; Jia RH; Bao Y
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2439-42. PubMed ID: 18036328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients.
    Kang YS; Song HK; Lee MH; Ko GJ; Cha DR
    Diabetes Res Clin Pract; 2010 Aug; 89(2):141-9. PubMed ID: 20409603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells.
    Park J; Ryu DR; Li JJ; Jung DS; Kwak SJ; Lee SH; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim K; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2008 Sep; 295(3):F749-57. PubMed ID: 18579703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like effects of visfatin on human osteoblasts.
    Xie H; Tang SY; Luo XH; Huang J; Cui RR; Yuan LQ; Zhou HD; Wu XP; Liao EY
    Calcif Tissue Int; 2007 Mar; 80(3):201-10. PubMed ID: 17340225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic beta-cells.
    Brown JE; Onyango DJ; Ramanjaneya M; Conner AC; Patel ST; Dunmore SJ; Randeva HS
    J Mol Endocrinol; 2010 Mar; 44(3):171-8. PubMed ID: 19906834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
    Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
    Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
    Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
    Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-linked kinase acts as a pro-survival factor against high glucose-associated osmotic stress in human mesangial cells.
    Ohnishi M; Hasegawa G; Yamasaki M; Obayashi H; Fukui M; Nakajima T; Ichida Y; Ohse H; Mogami S; Yoshikawa T; Nakamura N
    Nephrol Dial Transplant; 2006 Jul; 21(7):1786-93. PubMed ID: 16611685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of osteopontin upregulation on mesangial cells growth and collagen synthesis induced by intermittent high glucose.
    Sun J; Xu Y; Deng H; Sun S; Dai Z; Sun Y
    J Cell Biochem; 2010 Apr; 109(6):1210-21. PubMed ID: 20135641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X; Li C; Li X; Cai L
    Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens induce visfatin expression in 3T3-L1 cells.
    Zhou J; Seidel ER
    Peptides; 2010 Feb; 31(2):271-4. PubMed ID: 20004694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
    Kang YS; Ko GJ; Lee MH; Song HK; Han SY; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2009 Jan; 24(1):73-84. PubMed ID: 18682491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.